Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Treating Sarcopenic Obesity in the Era of Incretin Therapies: Perspectives and Challenges

Diabetes(2025)10.2337/dbi25-0004Source: DataRank Database

Treating Sarcopenic Obesity in the Era of Incretin Therapies: Perspectives and Challenges is a research paper published in Diabetes (2025). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 11.73)OA: bronzeTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

John A. Batsis ORCID,Alissa S. Chen ORCID

Live enrichment

PubMed:40644314 PMC:PMC12645253 OpenAlex:https://openalex.org/W4412203922

National Institute on Aging

Grant: P30DK056350-23

National Institute on Aging

Grant: R01 AG071663

National Institute on Aging

Grant: T32 AG01914

NIDDK NIH HHS

Grant: P30 DK056350

NIA NIH HHS

Grant: R01 AG077163

NIA NIH HHS

Grant: T32 AG019134

FWCI

11.73

Citation Percentile

1.0%

Influential Citations

Citation Trend

2025

2026

bronzeLicense: https://www.diabetesjournals.org/journals/pages/license

journalhttps://diabetesjournals.org/diabetes/article-pdf/doi/10.2337/dbi25-0004/836727/dbi250004.pdf

publisherhttps://diabetesjournals.org/diabetes/article-pdf/doi/10.2337/dbi25-0004/836727/dbi250004.pdf

publisherhttps://diabetesjournals.org/diabetes/article-pdf/74/12/2179/836727/dbi250004.pdf

journalhttps://doi.org/10.2337/dbi25-0004

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40644314

Fields of Study

Diabetes Treatment and ManagementBariatric Surgery and OutcomesNutrition and Health in AgingMedicineHumansSarcopeniaObesityIncretinsGlucagon-Like Peptide-1 Receptor AgonistsLiraglutideGlucagon-Like Peptides

MeSH Terms

LiraglutideGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like PeptidesHumansObesityIncretinsSarcopenia

Keywords

Sarcopenic obesitySarcopeniaMedicineDiscontinuationType 2 diabetesLiraglutideAdverse effectObesityWeight lossIncretinInternal medicineEndocrinologyBioinformaticsDiabetes mellitusBiology

Sustainable Development Goals

SDG 0: Good health and well-being